UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 441

Sortiert nach

Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group

Maturitas, 2005-05, Vol.51 (1), p.21

2005

Volltextzugriff (PDF)

Therapeutic options for postmenopausal female sexual dysfunction

Climacteric : the journal of the International Menopause Society, 2010-04, Vol.13 (2), p.103-120

2010

Volltextzugriff (PDF)

Survival in Early Breast Cancer Patients Is Favorably Influenced by a Natural Humoral Immune Response to Polymorphic Epithelial Mucin

Journal of clinical oncology, 2000-02, Vol.18 (3), p.574-583

2000

Volltextzugriff (PDF)

The Maturitas Master Class on Hormones and the Breast

Maturitas, 2004-09, Vol.49 (1), p.1-1

Kenemans, P.

2004

Volltextzugriff (PDF)

Emerging selective estrogen receptor modulators : Special focus on effects on coronary heart disease in postmenopausal women

Drugs (New York, N.Y.), 2006-01, Vol.66 (2), p.191-221

2006

Volltextzugriff (PDF)

Breast cancer and post-menopausal hormone therapy

Baillière's best practice & research. Clinical endocrinology & metabolism, 2003-03, Vol.17 (1), p.123-137

2003

Volltextzugriff (PDF)

Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo‐controlled study

Journal of internal medicine, 2006-02, Vol.259 (2), p.199-208

2006

Volltextzugriff (PDF)

Oncogenic pathways in hereditary and sporadic breast cancer

Maturitas, 2008-09, Vol.61 (1-2), p.141

2008

Volltextzugriff (PDF)

The Effects of Tibolone in Older Postmenopausal Women

The New England journal of medicine, 2008-08, Vol.359 (7), p.697-708

2008

Volltextzugriff (PDF)

Estrogenic uterovaginal effects of oral estetrol in the modified Allen-Doisy test

Climacteric : the journal of the International Menopause Society, 2008, Vol.11 (S1), p.22-28

2008

Volltextzugriff (PDF)

Histopathologic Features of Genetically Determined Ovarian Cancer

International journal of gynecological pathology, 2002-10, Vol.21 (4), p.407-411

2002

Volltextzugriff (PDF)

I356 Is the internet an asset in daily practice? The Madonna Programme as an example

International journal of gynecology and obstetrics, 2009-10, Vol.107 (S2), p.S88-S88

2009

Volltextzugriff (PDF)

Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

The lancet oncology, 2009-02, Vol.10 (2), p.135-146

2009

Volltextzugriff (PDF)

Tissue specificity of sex hormones and so-called modulation of receptors and enzymes

Maturitas, 2001-01, Vol.37 (3), p.145-146

Kenemans, P.

2001

Volltextzugriff (PDF)

Effects of transdermal and oral oestrogen replacement therapy on C-reactive protein levels in postmenopausal women: a randomised, placebo-controlled trial

Thrombosis and haemostasis, 2002-10, Vol.88 (4), p.605

2002

Volltextzugriff (PDF)

Impaired procoagulant-anticoagulant balance during hormone replacement therapy? A randomised, placebo-controlled 12-week study

Thrombosis and haemostasis, 2000-01, Vol.83 (1), p.29

2000

Volltextzugriff (PDF)

Tubal ligation and risk of ovarian cancer

The Lancet (British edition), 2001-09, Vol.358 (9284), p.844-844

2001

Volltextzugriff (PDF)

Oral Estradiol Decreases Plasma Homocysteine, Vitamin B 6 , and Albumin in Postmenopausal Women But Does Not Change the Whole-Body Homocysteine Remethylation and Transmethylation Flux

The journal of clinical endocrinology and metabolism, 2005-04, Vol.90 (4), p.2218-2224

2005

Volltextzugriff (PDF)

Oncogenic pathways in hereditary and sporadic breast cancer

Maturitas, 2004-09, Vol.49 (1), p.34-43

2004

Volltextzugriff (PDF)

Reprint of Oncogenic pathways in hereditary and sporadic breast cancer

Maturitas, 2008, Vol.61 (1), p.141-150

2008

Volltextzugriff (PDF)

Hormone replacement therapy and plasma homocysteine levels

Obstetrics and gynecology (New York. 1953), 1999-10, Vol.94 (4), p.485-491

1999

Volltextzugriff (PDF)

Drug Resistance-Associated Marker Lrp for Prediction of Response to Chemotherapy and Prognoses in Advanced Ovarian Carcinoma

JNCI : Journal of the National Cancer Institute, 1995-08, Vol.87 (16), p.1230-1237

1995

Volltextzugriff (PDF)

PCR‐based high‐risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears

International journal of cancer, 1996-12, Vol.68 (6), p.766-769

1996

Volltextzugriff (PDF)

Less mammographic density after nasal versus oral administration of postmenopausal hormone therapy

Climacteric : the journal of the International Menopause Society, 2011-12, Vol.14 (6), p.683-688

2011

Volltextzugriff (PDF)

Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation

European journal of cancer (1990), 2007-07, Vol.43 (10), p.1556-1563

2007

Volltextzugriff (PDF)

1 – 25 von 441

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(419)
Mit Volltextzugriff
(384)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group

Therapeutic options for postmenopausal female sexual dysfunction

Survival in Early Breast Cancer Patients Is Favorably Influenced by a Natural Humoral Immune Response to Polymorphic Epithelial Mucin

The Maturitas Master Class on Hormones and the Breast

Emerging selective estrogen receptor modulators : Special focus on effects on coronary heart disease in postmenopausal women

Breast cancer and post-menopausal hormone therapy

Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo‐controlled study

Oncogenic pathways in hereditary and sporadic breast cancer

The Effects of Tibolone in Older Postmenopausal Women

Estrogenic uterovaginal effects of oral estetrol in the modified Allen-Doisy test

Histopathologic Features of Genetically Determined Ovarian Cancer

I356 Is the internet an asset in daily practice? The Madonna Programme as an example

Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

Tissue specificity of sex hormones and so-called modulation of receptors and enzymes

Effects of transdermal and oral oestrogen replacement therapy on C-reactive protein levels in postmenopausal women: a randomised, placebo-controlled trial

Impaired procoagulant-anticoagulant balance during hormone replacement therapy? A randomised, placebo-controlled 12-week study

Tubal ligation and risk of ovarian cancer

Oral Estradiol Decreases Plasma Homocysteine, Vitamin B 6 , and Albumin in Postmenopausal Women But Does Not Change the Whole-Body Homocysteine Remethylation and Transmethylation Flux

Oncogenic pathways in hereditary and sporadic breast cancer

Reprint of Oncogenic pathways in hereditary and sporadic breast cancer

Hormone replacement therapy and plasma homocysteine levels

Drug Resistance-Associated Marker Lrp for Prediction of Response to Chemotherapy and Prognoses in Advanced Ovarian Carcinoma

PCR‐based high‐risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears

Less mammographic density after nasal versus oral administration of postmenopausal hormone therapy

Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation

Suchergebnisse filtern